What You Must Know About Trackloop Analytics Corp's (CNSX:TOOL) Beta Value

    If you're interested in Trackloop Analytics Corp (CNSX:TOOL), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market.

    Some stocks see their prices move in concert with the market. Others tend towards stronger, gentler or unrelated price movements. Beta is a widely used metric to measure a stock's exposure to market risk (volatility). Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful. The first thing to understand about beta is that the beta of the overall market is one. Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

    View our latest analysis for Trackloop Analytics

    Advertisement

    What we can learn from TOOL's beta value

    Looking at the last five years, Trackloop Analytics has a beta of 1.38. The fact that this is well above 1 indicates that its share price movements have shown sensitivity to overall market volatility. If this beta value holds true in the future, Trackloop Analytics shares are likely to rise more than the market when the market is going up, but fall faster when the market is going down. Share price volatility is well worth considering, but most long term investors consider the history of revenue and earnings growth to be more important. Take a look at how Trackloop Analytics fares in that regard, below.

    CNSX:TOOL Income Statement Export November 27th 18
    CNSX:TOOL Income Statement Export November 27th 18

    Could TOOL's size cause it to be more volatile?

    Trackloop Analytics is a noticeably small company, with a market capitalisation of CA$5.8m. Most companies this size are not always actively traded. Relatively few investors can influence the price of a smaller company, compared to a large company. This could explain the high beta value, in this case.

    What this means for you:

    Beta only tells us that the Trackloop Analytics share price is sensitive to broader market movements. This could indicate that it is a high growth company, or is heavily influenced by sentiment because it is speculative. Alternatively, it could have operating leverage in its business model. Ultimately, beta is an interesting metric, but there's plenty more to learn. In order to fully understand whether TOOL is a good investment for you, we also need to consider important company-specific fundamentals such as Trackloop Analytics’s financial health and performance track record. I urge you to continue your research by taking a look at the following:

    1. Financial Health: Are TOOL’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
    2. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

    To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

    The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

    Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

    Advertisement

    Weekly Picks

    LO
    Lou_Basenese
    OPTH logo
    Lou_Basenese on Optimi Health ·

    The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

    Fair Value:US$1155.3% undervalued
    50 users have followed this narrative
    2 users have commented on this narrative
    9 users have liked this narrative
    WE
    WealthAP
    NOVO B logo
    WealthAP on Novo Nordisk ·

    Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

    Fair Value:DKK 407.7719.9% undervalued
    69 users have followed this narrative
    0 users have commented on this narrative
    8 users have liked this narrative
    VA
    ValueInvestingSubstack
    ZTS logo
    ValueInvestingSubstack on Zoetis ·

    Zoetis down -50% over the past year

    Fair Value:US$92.9217.2% undervalued
    23 users have followed this narrative
    0 users have commented on this narrative
    9 users have liked this narrative
    CE
    CentryResearch
    LEU logo
    CentryResearch on Centrus Energy ·

    Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

    Fair Value:US$1907.4% undervalued
    24 users have followed this narrative
    0 users have commented on this narrative
    11 users have liked this narrative

    Updated Narratives

    BR
    Brunhilde_Wagner
    CPRT logo
    Brunhilde_Wagner on Copart ·

    Compounder to Cash Generator in Real Time

    Fair Value:US$2710.3% overvalued
    1 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    WI
    WisetoWealth
    PYPL logo
    WisetoWealth on PayPal Holdings ·

    The Underrated Transformation of a Digital Payments Giant

    Fair Value:US$90.3137.9% undervalued
    6 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    BL
    Blagget
    TERA logo
    Blagget on Terra Balcanica Resources ·

    The C$4M Explorer Positioned to Become Europe's First Antimony Mine

    Fair Value:CA$0.487.5% undervalued
    3 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative

    Popular Narratives

    CU
    MSFT logo
    CubanEros on Microsoft ·

    A wonderful business at reasonable price.

    Fair Value:US$419.917.3% undervalued
    85 users have followed this narrative
    0 users have commented on this narrative
    6 users have liked this narrative
    OS
    oscargarcia
    NVDA logo
    oscargarcia on NVIDIA ·

    The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

    Fair Value:US$28029.8% undervalued
    193 users have followed this narrative
    9 users have commented on this narrative
    15 users have liked this narrative
    BE
    PYPL logo
    benjamin_lvieq on PayPal Holdings ·

    PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

    Fair Value:US$6513.7% undervalued
    72 users have followed this narrative
    2 users have commented on this narrative
    11 users have liked this narrative

    Trending Discussion

    DE
    TDOC logo
    derek_3wsdg on Teladoc Health ·

    You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

    1
    |
    0
    AN
    CSMG3 logo
    andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

    Gostei

    0
    |
    0